Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies.
about
Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.Protein carbamylation in kidney disease: pathogenesis and clinical implicationsAnti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.Protein carbamylation is a hallmark of agingRheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseasesAntibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.Anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort.Managing rheumatic and musculoskeletal diseases - past, present and future.Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.From autoantibody research to standardized diagnostic assays in the management of human diseases - report of the 12th Dresden Symposium on Autoantibodies.Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis.The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting.Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factorThe specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.Cutting edge data in autoimmunity: as presented in the 9th International Congress of Autoimmunity.Editorial: Anti-Citrullinated Protein Antibody, Anti-Carbamylated Protein Antibody, and Rheumatoid Arthritis: Azurophilic Granules Sing the Blues.Brief Report: Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis Patients Are Reactive With Specific Epitopes of the Human Fibrinogen β-Chain.Carbamylation of the amino-terminal residue (Gly1) of mouse serum amyloid A promotes amyloid formation in a cell culture model.Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammationAnticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system
P2860
Q33904381-B37FC5BC-5780-4B26-835D-0FB6BBBDA0B4Q34403945-19B08DBF-5772-4106-8AE5-15314341774EQ35149378-4AEA7584-90F3-4972-8448-71308D61D1AFQ35533807-DC766EA0-AC9C-444E-90FE-D8F71794520AQ36082681-CA8D0DF4-DC81-407A-9F7E-310C43459060Q36563327-EFCA47EC-E7CD-4D63-B3AC-CD8BD88A0600Q36565997-BCAC7583-E9B7-4C56-A5CD-D90060D86CB4Q36918405-667ECC3E-77F9-43F6-A590-88C50E473043Q37442781-9C6A187A-9480-4CA8-A71D-307F732F6582Q37470470-A1C9D37A-3179-4BF3-B5C0-32BDFE516D51Q38602504-F0D95CDC-24ED-41A9-9D9C-2F67B9AB282FQ38670973-865A6357-68FE-401F-A982-91DD6B9AB815Q38737789-769A78E3-4E67-480C-9B23-4337362F315BQ38851084-EDBEE034-2609-4087-AF14-9A010994B99EQ40117130-6612349D-CCF3-4A76-BE5B-5DF4731B19F3Q41146137-64B4ECBD-AEAA-4A06-B711-AC925F9C2F23Q41431357-8FAC2BF3-E418-4568-A8B1-4A00467CB0C7Q42356893-630B11BE-A3D5-41D7-B7E6-EA76C98E20DEQ42643869-46B42A37-854D-462A-9876-16BF5CD16BBFQ43158822-A841BF50-3CDC-4B4A-9A68-3CD50D74D480Q45836428-3AC1D8F5-0AFE-48D3-9176-2FD98A38142CQ47884810-72BA1B10-51EB-4105-B878-7F413C711334Q51098357-9BD80841-343D-4660-9A8B-A7A7582B5142Q51351788-D4AC4CC7-5C53-48A3-B306-CA004E70B7F1Q53393095-28D16A1B-BE3E-4050-A5F8-6798576E30C1Q58234673-61AB9C5A-B4F9-43AE-910E-16858A31D055Q58234739-62DBA40B-DD64-4ACF-AE92-C835F74A8A6A
P2860
Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Carbamylation and antibodies a ...... mmunity and other pathologies.
@en
type
label
Carbamylation and antibodies a ...... mmunity and other pathologies.
@en
prefLabel
Carbamylation and antibodies a ...... mmunity and other pathologies.
@en
P2093
P50
P1433
P1476
Carbamylation and antibodies a ...... mmunity and other pathologies.
@en
P2093
George M C Janssen
Jan W Drijfhout
Rene E M Toes
Tom W J Huizinga
P304
P356
10.1016/J.AUTREV.2013.10.008
P577
2013-10-28T00:00:00Z